You are here

Presage Biosciences

Bristol-Myers opens up the Phase 0 pathway in testing its new cancer therapies, following in Celgene’s footsteps

Endpoints

Tue, 08/27/19 - 09:55 am

Bristol-Myers Squibb

Presage Biosciences

Phase 0 testing

drug development

Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology

BioSpace

Tue, 07/17/18 - 11:23 pm

Presage Biosciences

Takeda's Millennium re-ups with Presage on cancer drug combo effort

Fierce Biotech

Wed, 11/12/14 - 11:46 am

Millennium Pharmaceuticals

Presage Biosciences

FierceBiotech's 2013 Fierce 15

Fierce Biotech

Wed, 09/25/13 - 01:04 pm

Acetylon Pharmaceuticals

Jounce Therapeutics

Kala Pharmaceuticals

Moderna Therapeutics

Presage Biosciences

Nimbus Discovery